当前位置: X-MOL 学术Hepatology › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The novel tumor suppressor IRF2BP2 regulates Hippo pathway in liver cancer via a feedback loop
Hepatology ( IF 12.9 ) Pub Date : 2020-02-16 , DOI: 10.1002/hep.30961
Xue Feng 1 , Tiantian Lu 1 , Jinhui Li 1 , Ruizeng Yang 1 , Liqiao Hu 2 , Yi Ye 3 , Feifei Mao 4 , Lingli He 1 , Jinjin Xu 1 , Zuoyun Wang 1 , Yingbin Liu 5 , Yonglong Zhang 1 , Hongbin Ji 1, 3 , Yun Zhao 1, 3 , Shuqun Cheng 4 , Wei Tian 2 , Lei Zhang 1, 3
Affiliation  

The conserved Hippo pathway regulates organ size, tissue homeostasis, and tumorigenesis. Interferon regulatory factor 2 binding protein 2 (IRF2BP2) was originally identified as a transcriptional corepressor. However, the association between IRF2BP2 and the Hippo pathway remains largely unknown. In addition, the biological function and regulation mechanism of IRF2BP2 in liver cancer are poorly understood.

中文翻译:

新型抑癌基因 IRF2BP2 通过反馈回路调节肝癌中的 Hippo 通路

保守的 Hippo 通路调节器官大小、组织稳态和肿瘤发生。干扰素调节因子 2 结合蛋白 2 (IRF2BP2) 最初被确定为转录辅助抑制因子。然而,IRF2BP2 和 Hippo 通路之间的关联在很大程度上仍然未知。此外,IRF2BP2在肝癌中的生物学功能和调控机制也知之甚少。
更新日期:2020-02-16
down
wechat
bug